Public Survey on Breath Testing for Health and Disease

Sponsor
Imperial College London (Other)
Overall Status
Recruiting
CT.gov ID
NCT06081452
Collaborator
(none)
1,000
1
18
55.4

Study Details

Study Description

Brief Summary

A brief survey for the public to determine interest in health surveillance and disease detection

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Survey

Detailed Description

There are numerous barriers and favourable conditions that affect the acceptability of a screening test for cancer. Such factors have been investigated in the context of some of the current screening programs. Through this survey the investigators want to increase researcher awareness of these factors with the hope that this information will aid policy makers and guide future research.

There has been widening public interest in general health-surveillance in addition to disease detection. Breath testing has the potential to be a one-for-all non-invasive test to detect health domains. Through this survey, the investigators wish to understand public opinions about breath testing for health.

This survey consists of questions aiming to gather views on non-invasive testing for health and disease.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Ecologic or Community
Time Perspective:
Prospective
Official Title:
Public Survey on Breath Testing for Health and Disease
Actual Study Start Date :
Jun 17, 2023
Anticipated Primary Completion Date :
Jun 17, 2024
Anticipated Study Completion Date :
Dec 17, 2024

Arms and Interventions

Arm Intervention/Treatment
Public

General public to be approached to answer this survey via GPs, charities and exhibitions such as Great Exhibition Road Festival.

Behavioral: Survey
Members of the public will be asked to complete a survey that collects information on individuals perception of health and disease and their views on breath testing.

Outcome Measures

Primary Outcome Measures

  1. Acceptability of breath testing [6 months]

    Proportion of people that find breath testing an acceptable means to determine health or disease

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Member of the public above the age of 18
Exclusion Criteria:
  • Member of the public below the age of 18

Contacts and Locations

Locations

Site City State Country Postal Code
1 Imperial College London London United Kingdom

Sponsors and Collaborators

  • Imperial College London

Investigators

  • Study Director: George Hanna, PhD, Imperial College London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College London
ClinicalTrials.gov Identifier:
NCT06081452
Other Study ID Numbers:
  • 6634264
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 17, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 17, 2023